Keeping Pace in GI Cancer: Advances in Immunotherapy in MSI-H/dMMR Metastatic Colorectal Cancer
Host: Edward Chu, MD
Guest: Michael J. Overman, MD
Recent immunotherapy approvals have changed the treatment paradigm for first and subsequent lines of treatment for patients with microsatellite-high or mismatch repair deficient metastatic colorectal cancer. Join us as we deep dive into recent and newly emergent data to better understand how to bring these advances into the clinic.